Last reviewed · How we verify

Zoledronate

Children's Hospital Medical Center, Cincinnati · FDA-approved active Small molecule

At a glance

Generic nameZoledronate
Also known aszoledronic acid; zolendronate, Zoledronic acid, zoledronic acid, Zometa, Zoledronic acid intravenous once a year
SponsorChildren's Hospital Medical Center, Cincinnati
TargetButyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase
ModalitySmall molecule
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: